Welcome to our dedicated page for Ehealth SEC filings (Ticker: EHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The eHealth, Inc. (NASDAQ: EHTH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a public company in the insurance agencies and brokerages industry, eHealth uses SEC filings to report material events, financial results, governance changes, and capital structure developments that are relevant to investors evaluating EHTH stock.
eHealth regularly files current reports on Form 8-K to announce significant developments. Recent 8-K filings describe quarterly financial results, including press releases for the second and third quarters of a fiscal year, and provide information about the company’s financial condition. Other 8-Ks document amendments to credit agreements, such as an extension of the maturity date of a term loan credit agreement with Blue Torch Finance LLC and the entry into a new asset-based revolving credit facility with Manulife | Comvest Credit Partners, along with the use of proceeds to repay existing debt and support strategic initiatives.
Filings also address corporate governance and compensation matters. eHealth has reported on amendments and restatements of its bylaws, including changes to meeting notice deadlines, definitions relevant to principal competitors, and provisions related to indemnification and insurance for directors, officers, employees and agents. Other filings discuss the approval and amendment of equity incentive plans, inducement and equity awards for executives and directors, and the results of stockholder votes on director elections, executive compensation, and plan amendments.
Leadership changes and board composition are another focus of eHealth’s SEC reports. Form 8-K filings describe CEO transition arrangements, the appointment of a new chief executive officer, related severance and compensation agreements, and the resignation and appointment of directors, including those designated under an investment agreement with a preferred stock investor. These disclosures help investors understand how management and board oversight are evolving.
On Stock Titan, eHealth’s SEC filings are paired with AI-powered summaries that help explain the contents of lengthy documents such as 8-Ks and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. Real-time updates from EDGAR ensure that new filings, including any insider transaction reports on Form 4 or other material disclosures, are quickly reflected. The AI summaries highlight key points, such as changes in capital structure, governance updates, and important risk or operational information, allowing users to review the implications for EHTH without reading every line of each filing.
By using this filings page, investors can efficiently review eHealth’s regulatory history, track recurring themes in its disclosures, and connect filing information with the company’s news releases and business description. This context can support deeper analysis of eHealth’s financial performance, risk profile, and strategic direction as presented in its official SEC documents.
eHealth, Inc. (EHTH) filed a Form 4 disclosing that independent director Beth A. Brooke received an annual equity grant of 34,574 restricted stock units (RSUs) on 17 June 2025. Each RSU represents one share of common stock and was issued at $0 cost under the company’s 2024 Equity Incentive Plan. The RSUs vest in four equal quarterly installments beginning on the grant date, with accelerated vesting in full either the day before the next annual shareholder meeting or upon a Change-in-Control, contingent on continued service. After the grant, Brooke’s beneficial ownership increased to 132,833 directly held shares. No derivative transactions were reported. The filing reflects routine non-employee director compensation and does not signal any strategic change or material impact on the company’s capital structure.
eHealth (EHTH) Director Erin L. Russell received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program. The RSUs were granted at $0 cost and represent the right to receive an equivalent number of common shares upon vesting.
The RSUs will vest in four equal quarterly installments starting from June 17, 2025, subject to continued service. Following this grant, Russell beneficially owns 115,037 shares directly. Accelerated vesting provisions apply if:
- The day before the next annual stockholder meeting
- In the event of a Change in Control, subject to continued service
This Form 4 filing was executed by Sonwha Lee as attorney-in-fact for Russell on June 20, 2025, within the required reporting timeline.
eHealth (EHTH) Director Cesar M. Soriano received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program. The RSUs were granted at $0 cost and will vest in four equal quarterly installments starting from the grant date.
Following this transaction, Soriano beneficially owns 110,216 shares of eHealth common stock directly. The RSUs are subject to accelerated vesting in two scenarios:
- The day before the next annual stockholder meeting
- Upon a Change in Control event, provided the director maintains service provider status
This Form 4 filing was submitted on June 28, 2025, with the signature executed by Sonwha Lee as attorney-in-fact for Soriano on June 20, 2025.
eHealth Director Dale B. Wolf reported the acquisition of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's annual non-employee director compensation. The RSUs were granted at $0 cost and will vest in four equal quarterly installments starting from the grant date.
Key details of the transaction:
- Following the transaction, Wolf directly owns 123,133 shares of common stock
- Additionally holds 62,932 shares indirectly through the Dale B. Wolf Generation Skipping Trust
- RSUs will vest fully if either: (1) the day before next annual stockholder meeting, or (2) upon a Change in Control
- Vesting is contingent on continued service as defined in the 2024 Equity Incentive Plan
This Form 4 filing, signed by attorney-in-fact Sonwha Lee on June 20, 2025, demonstrates standard board compensation practices and aligns director interests with shareholders through equity-based awards.
eHealth (EHTH) Director A. John Hass received a significant equity grant on June 17, 2025, consisting of 34,574 restricted stock units (RSUs) as part of the company's annual non-employee director compensation program. Following this transaction, Hass's direct ownership increased to 121,893 shares.
The RSUs were granted at $0 exercise price and will vest in four equal quarterly installments starting from June 17, 2025. Key accelerated vesting provisions include:
- Full vesting on the day before the next annual stockholder meeting
- Full vesting upon a Change in Control event
Both acceleration scenarios require continued service as a board member. This grant was made under the company's 2024 Equity Incentive Plan and represents standard board compensation practices, demonstrating alignment with shareholder interests through equity-based compensation.